# Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca

> **NCT02144194** · PHASE2 · UNKNOWN · sponsor: **Cancer Research Group - Collaborative Group, Beirut, Lebanon.** · enrollment: 65 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Vinorelbine-Docetaxel
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT02144194
- **Lead sponsor:** Cancer Research Group - Collaborative Group, Beirut, Lebanon.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02144194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02144194, "Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02144194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*